Provided by Tiger Trade Technology Pte. Ltd.

Spruce Biosciences, Inc.

51.58
-0.4050-0.78%
Pre-market: 51.14-0.4400-0.85%05:24 EDT
Volume:62.31K
Turnover:3.18M
Market Cap:148.24M
PE:-1.34
High:53.00
Open:52.48
Low:49.03
Close:51.99
52wk High:240.00
52wk Low:7.26
Shares:2.87M
Float Shares:2.29M
Volume Ratio:1.21
T/O Rate:2.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-38.4300
EPS(LYR):-50.8298
ROE:-105.98%
ROA:-40.03%
PB:1.77
PE(LYR):-1.01

Loading ...

Analysts Offer Insights on Healthcare Companies: Brookdale Senior Living (BKD) and Spruce Biosciences (SPRB)

TIPRANKS
·
Aug 21

Longeveron Q2 Net Loss Widens on Higher Legal, Clinical Trial Costs

Reuters
·
Aug 13

Spruce Biosciences Q2 FY26 Net Loss Widens to $16.23 Million; R&D Expenses Rise to $12.16 Million

Reuters
·
Aug 12

Spruce Biosciences, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 12

Spruce Biosciences Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 12

Spruce Biosciences - Bla Submission for Ta-Ert for Mps Iiib Anticipated in Q4 2026

THOMSON REUTERS
·
Aug 12

Spruce Biosciences Q2 EPS USD -6.68

THOMSON REUTERS
·
Aug 12

Spruce Biosciences Q2 Operating Expenses USD 16.512 Million

THOMSON REUTERS
·
Aug 12

Cure Sanfilippo Foundation, National MPS Society Invest $5.5 Million in Spruce Biosciences

Reuters
·
Aug 12

Spruce Biosciences, - Cure Sanfilippo Foundation and National Mps Society Invest $5.50 Mln in Spruce Biosciences

THOMSON REUTERS
·
Aug 12

Spruce Biosciences, - Ta-Ert Expanded Access Program Expected to Initiate in Q4 2026

THOMSON REUTERS
·
Aug 12

Spruce Biosciences, Inc. Expected to Post a Loss of $5.80 a Share - Earnings Preview

Reuters
·
Aug 10

Spruce Biosciences Names Jessica Cohen Pfeffer Vice President, Clinical Development

Reuters
·
Aug 03

Spruce Biosciences Appoints Jessica Cohen Pfeffer, M.d., as Vice President, Clinical Development

THOMSON REUTERS
·
Aug 03

Spruce Biosciences Moves Tralesinidase Alfa Into Phase 3, Putting Rare Disease Upside in Focus

TIPRANKS
·
Jul 31

Spruce Biosciences Files Form 3 for Chief Medical Officer Adrian W. Quartel

Reuters
·
Jul 30

Spruce Biosciences Names Adrian Quartel Chief Medical Officer

Reuters
·
Jul 27

Spruce Biosciences Appoints Adrian Quartel, M.d., Ffpm, as Chief Medical Officer

THOMSON REUTERS
·
Jul 27

Spruce Biosciences Initiated at Buy by B. Riley Securities

Dow Jones
·
Jul 13

B. Riley Initiates Spruce Biosciences at Buy With $160 Price Target

MT Newswires Live
·
Jul 13